Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...
Canada Pension Plan Investment Board (CPP Investments) ended its third quarter on December 31, 2024, with net assets of $699.6 billion, compared to $675.1 billion ...